![]() "Alan is uniquely qualified to serve in this important role given his broad pharmaceutical industry experience and his keen understanding of the growth opportunities for Endo as we execute our strategy to diversify and expand our business into new therapeutic areas and medical markets. "I am very pleased to announce the appointment of Alan as our chief financial officer," said David Holveck, president and chief executive officer of Endo Pharmaceuticals. He received a bachelor's degree from Princeton University and a master's degree from New York University's Stern School of Business. Levin began his career in public accounting. Most recently, he was executive vice president and chief financial officer of Moksha8 Pharmaceuticals, Inc., a privately held, specialty pharmaceuticals company focused in Latin America and other emerging markets. where he worked for 20 years in a variety of executive positions of increasing responsibility, including treasurer, and senior vice president of finance and strategic management for the company's research and development organization. Levin was senior vice president and chief financial officer of Pfizer, Inc. Levin as the company's executive vice president and chief financial officer, effective June 1, 2009. ![]() ![]() CHADDS FORD, Pa., May 7 /PRNewswire-FirstCall/ - Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of Alan G. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |